UMIN000047230
Treatment effect and prediction survival of Immune checkpoint inhibitors by FDG-PET/CT: A multicenter study
Treatment effect and prediction survival of Immune checkpoint inhibitors by FDG-PET: A multicenter prospective study
Hyogo College of Medicine·Not Applicable·University Hospital Medical Information Network·otherNot yet recruiting
Study focus
- Disease/Condition
- Lung cancer
- Study type
- Interventional
- Intervention type
- other
Sponsor & location
- Primary sponsor
- Hyogo College of Medicine
- Location
- Japan
Timeline & enrollment
- Phase
- Not Applicable
- Start date
- Aug 01, 2022
- End date
- N/A
ICD-10 classifications
Carcinoma in situ: Bronchus and lungSecondary malignant neoplasm of lungMalignant neoplasm of bronchus and lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm: Overlapping lesion of bronchus and lung
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000047230
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000047230 through Pure Global AI's free database. This Not Applicable trial is sponsored by Hyogo College of Medicine and is currently Not yet recruiting. The study focuses on Lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.